![glp 1 agonist 종류 동향리포트]GLP-1 수용체 작용제: 당뇨병 치료에서 체중 감량 치료제로의 진화 | Bio리포트 > 동향 당뇨병(Diabetes): 약물요법-경구혈당강하제(Oral Antidiabetic Drug) -](https://www.ibric.org/_attach/bric/editor-image/2024/09/knmJPgFTBCMncfCXGnwQnkhyrX.png)
glp 1 agonist 종류 동향리포트]GLP-1 수용체 작용제: 당뇨병 치료에서 체중 감량 치료제로의 진화 | Bio리포트 > 동향 당뇨병(Diabetes): 약물요법-경구혈당강하제(Oral Antidiabetic Drug) -
Description
Future Outlook * GLP-1s may reshape care across obesity, metabolic disease, neurodegeneration, and even oncology and Longevity Medicine
![glp 1 agonist ]GLP-1 : | Bio > (Diabetes): -(Oral Antidiabetic Drug) -](https://metamedic.s3.ap-northeast-2.amazonaws.com/froala_Img/1672209715009.png%3Bbase64)
124,129 A common combination is GLP-1 with GIP or insulin-like growth factor
![glp 1 agonist ]GLP-1 : | Bio > (Diabetes): -(Oral Antidiabetic Drug) -](http://webzine.koita.or.kr/storage/app/public/media/public/media_library/f7/cf/20200826104639efa88c925fbb79f6f7e39cb088e9ee0aa342fafd.jpg)
Lancet 394, 121130
![glp 1 agonist ]GLP-1 : | Bio > (Diabetes): -(Oral Antidiabetic Drug) -](https://images.ctfassets.net/4f3rgqwzdznj/2zOOXVnmS5ExpkOMLBGlOZ/9626d72ba81ecfb39b173a74b699ced2/23-02_Comparison_of_GLP-1_Agonist_Drugs.png)
Although no findings have yet been made with GIP receptor antagonists in this field, the findings suggests that the GIP system is involved in the regulation of central nervous system-mediated anorexigenic and emetic behaviors (106)
![glp 1 agonist ]GLP-1 : | Bio > (Diabetes): -(Oral Antidiabetic Drug) -](https://cdn.hitnews.co.kr/news/photo/202309/48180_62886_234.jpg)
With proper monitoring and support, you can manage PCOS while minimizing risks and ensuring your treatment plan works for you
![glp 1 agonist ]GLP-1 : | Bio > (Diabetes): -(Oral Antidiabetic Drug) -](https://www.e-jkd.org/upload//thumbnails/t1-jkd-2021-22-2-126.png)
